Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Sitbon

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
The European Respiratory Journal|October 26, 2007
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 casesR Souza, M Humbert, B Sztrymf, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|October 20, 2010
Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centreD Montani, D S O'Callaghan, X Jaïs, et al.
Revue Des Maladies Respiratoires|March 5, 2018
[Pulmonary veno-occlusive disease]A Boucly, B Girerd, D Bourlier, et al.
Thorax|August 2, 2005
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenolO Sitbon, V V McLaughlin, D B Badesch, et al.
Revue Des Maladies Respiratoires|June 28, 2018
[Evaluation of cardiac MRI in the follow up assessment of patients with pulmonary arterial hypertension]A Chaouat, A Cherifi, O Sitbon, et al.
Respiratory Medicine and Research|September 27, 2019
Klippel-Trenaunay syndrome as a rare cause of chronic thromboemboembolic pulmonary hypertensionA Seferian, X Jaïs, L Savale, et al.
The European Respiratory Journal|June 23, 2009
Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive diseaseD Montani, X Jaïs, L C Price, et al.
The European Respiratory Journal|April 16, 2004
Chronic thromboembolic pulmonary hypertensionP Dartevelle, E Fadel, S Mussot, et al.
The European Respiratory Journal|August 9, 2002
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesisM Humbert, P Labrune, O Sitbon, et al.
Lancet (London, England)|October 13, 2001
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled studyR N Channick, G Simonneau, O Sitbon, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
The European Respiratory Journal|October 26, 2007
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 casesR Souza, M Humbert, B Sztrymf, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|October 20, 2010
Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centreD Montani, D S O'Callaghan, X Jaïs, et al.
Revue Des Maladies Respiratoires|March 5, 2018
[Pulmonary veno-occlusive disease]A Boucly, B Girerd, D Bourlier, et al.
Thorax|August 2, 2005
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenolO Sitbon, V V McLaughlin, D B Badesch, et al.
Revue Des Maladies Respiratoires|June 28, 2018
[Evaluation of cardiac MRI in the follow up assessment of patients with pulmonary arterial hypertension]A Chaouat, A Cherifi, O Sitbon, et al.
Respiratory Medicine and Research|September 27, 2019
Klippel-Trenaunay syndrome as a rare cause of chronic thromboemboembolic pulmonary hypertensionA Seferian, X Jaïs, L Savale, et al.
The European Respiratory Journal|June 23, 2009
Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive diseaseD Montani, X Jaïs, L C Price, et al.
The European Respiratory Journal|April 16, 2004
Chronic thromboembolic pulmonary hypertensionP Dartevelle, E Fadel, S Mussot, et al.
The European Respiratory Journal|August 9, 2002
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesisM Humbert, P Labrune, O Sitbon, et al.
Lancet (London, England)|October 13, 2001
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled studyR N Channick, G Simonneau, O Sitbon, et al.
Pageof 9